All times listed below are central time – USA (Chicago, IL). To find the event time in your local time, click here.
- December 4, 2021 5:00 AM CTVirtual Poster Session
Go online, before and after the meeting or anytime to review the submitted academic posters.
Click --> Review the iPosters from November 26, 2021 - January 31, 2022.
- December 4, 2021 06:30 AM CTWelcome Message
The Global Vitiligo Foundation president and the meeting chairs will welcome everyone to the symposium. A brief update about the GVF will be given.
- December 4, 2021 06:40 AM CTInvited Speaker # 1 - Thierry Passeron, MD, PhD
Oral Gliadin-Protected Superoxide Dismutase in Addition to Phototherapy for Treating Non-segmental Vitiligo: A 24-Week Prospective Randomized Placebo-Controlled Study
Summary:
The use of GP-SOD combined with NB-UVB could be a useful add-on in the treatment of vitiligo patients with excellent tolerability and safety. - December 4, 2021 7:00 AM CTAbstract #1 - Hyun Jeong Ju, MD
Progressive and Extensive Hypomelanosis of Childhood: A Novel Disease Entity Distinguished from Other Hypomelanotic Disorders
- December 4, 2021 7:10 AM CTAbstract #2 - Marcella Willemsen, MSc
Immunophenotypic Analysis Reveals Differences in Circulating Immune Cells in Peripheral Blood of Segmental and Non-segmental Vitiligo Patients
- December 4, 2021 7:20 AM CTAbstract #3 - Nanja van Geel, MD, PhD & Jolien Duponselle, MD
Image Analyses Systems to Calculate the Surface Area of Vitiligo Lesions: A Systematic Review of Measurement Properties
- December 4, 2021 7:30 AM CTInvited Speaker #2 - Caroline Lapoole, PhD
Modeling Microbial Impact on Autoimmune Depigmentation in Mice
- December 4, 2021 7:50 AM CTAbstract #4 - Saurabh Bhatia, MD
Efficacy of NB-UVB in Progressive Versus Non-progressive Non-segmental Vitiligo: A Prospective Comparative Study
- December 4, 2021 8:00 AM CTAbstract #5 - Khaled Ezzedine, MD, PhD
Efficacy and Safety of the Oral Janus Kinase 3/Tec Inhibitor Ritlecitinib (PF-06651600) In Adults With Active Non-segmental Vitiligo: Results From a Phase 2b, Randomized, Dose-Ranging Study With an Extension Period
- December 4, 2021 8:20 AM CTPoster Q&A #1
Click here to see the virtual posters
Authors:
Shiwangi Rana, MD
Anthropometric and Biochemical Evaluation for Assessing Risk of Metabolic Syndrome in Childhood Vitiligo: A Case Control StudyAlpana Mohta, MD
The Correlation of Extent, Distribution and Symptomatology of Vitiligo Patients With the Impairment in Quality-Of-LifeJu Hee Han, MD
Risk of Vitiligo After TransplantationFabiana Castro Porto Silva Lopes, MD
Insurance Coverage for Phototherapy for Vitiligo in Comparison to Psoriasis and Atopic Dermatitis - December 4, 2021 8:40 AM CTInvited Speaker #3 - Mauro Picardo, MD
Vitiligo: A Diverse Perspective
- December 4, 2021 9:00 AM CTAbstract #6 - Nicoline Post, MD
Meek Micrografting: A Novel Surgical Technique for the Treatment of Depigmentation
Speakers: - December 4, 2021 9:10 AM CTAbstract #7 - Helen Kitchen, MSc
A Qualitative Study to Explore the Content Validity of the Vitiligo Patient Priority Outcome (ViPPO) Measures
Speakers: - December 4, 2021 9:20 AM CTAbstract #8 - Camille Robinson, BS
Assessment of Vitiligo Patients’ Perceptions and Opinions About Their Dermatologists When They Were First Diagnosed
- December 4, 2021 9:30 AM CTInvited Speaker #4 - Marcella Willemsen, MSc
Impaired Ifn-γ-Induced PD-L1 Expression on Human Vitiligo Melanocytes
- December 4, 2021 9:50 AM CTPoster Q&A #2
Click here to see the virtual posters
Authors:
Lamia Elgarhy, MD
Transdermal Delivery of 5-Fluorouracil by Fractional CO2 Laser Versus Intralesional Injection of 5-Fluorouracil, Both Followed by Narrow Band UVB in Treatment of Stable VitiligoYvon Gauthier, BSA
Varicella-Zoster Virus (VZV) In Recent Segmental Vitiligo Skin : Pathological, Immunochemical and Ultrastructural Findings ( A Preliminary Study)Jalal Maghfour, Mpharm, PGDipCPP, PGDipPTQA
To Evaluate the Comparative Efficacy Between Visible Light Combined With UVA1 and Narrow Band Uv Light for the Treatment of Repigmentation in Generalized Vitiligo PatientsNicole Syder, MD
Vitiligo and Makeup: Analyzing Interest and Usage Trends in the 21st Century - December 4, 2021 10:20 AM CTWrap up and Summary of the Day
Join the chairs as the highlight some of the top topics of the day.
- December 4, 2021 10:20 AM CTVirtual Poster Session
Go online, before and after the meeting or anytime to review the submitted academic posters.
Click --> Review the iPosters from December 2, 2021 - January 31, 2022.
- December 5, 2021 5:00 AM CTVirtual Poster Session
Go online, before and after the meeting or anytime to review the submitted academic posters.
Click --> Review the iPosters from November 26, 2021 - January 31, 2022.
- December 5, 2021 6:30 AM CTWelcome Message From Chairs - Day 2
Join the chairs as they welcome everyone back and share some of the day's highlights.
- December 5, 2021 6:40 AM CTInvited Speaker #5 - David Rosmarin, MD
Efficacy and Safety of Ruxolitinib Cream for the Treatment of Vitiligo: 24-Week Results From 2 Randomized, Double-Blind Phase 3 Studies
- December 5, 2021 7:00 AM CTAbstract #9 - Prashant Giri, MSc
Altered Calcium-NFAT Signaling Pathway May Be Responsible for Decreased Suppressive Capacity of Tregs in Generalized Vitiligo Patients
- December 5, 2021 7:09 AM CTAbstract #10 - Janice Nathalie, MD
Health-Related Quality of Life in Pediatric Patients With Vitiligo
- December 5, 2021 7:18 AMAbstract #11 - Thierry Passeron, MD, PhD
Increased Cutaneous Activation of Innate Immunity and Pro-apoptotic CXCR3B in Patients With Segmental Vitiligo
- December 5, 2021 7:47 AM CTAbstract #12 - Andrew Thompson, DClinPsy
The Association Between Mental Health Conditions and Vitiligo: A Population-Based Cohort Study in the UK
- December 5, 2021 7:27 AM CTInvited Speaker #6 - Davinder Parsad, MD
- December 5, 2021 7:56 AM CTAbstract #13 - Nanis Ragab, MD
Early Localized Vitiligo, a Medical Emergency: Long Term Follow up Study
- December 5, 2021 8:05 AM CTAbstract #14 - Jessica Shiu, MD, PhD
Multimodal Analyses of Stable Vitiligo Skin Identify Tissue Interactions That Control Disease Persistence
- December 5, 2021 8:14 AM CTPoster Q&A #3
Click here to see the virtual posters
Authors:
Laila Benzekri, MD
Valacyclovir in Medical and Surgical Treatment of Segmental VitiligoAvina Jain, BA
Vitiligo or SCC - Which Is More Mental Threatening?Reenu T. George, MD, PhD
A Cross-Sectional Study of the Clinico-Epidemiological Profile of Childhood VitiligoPrakhar Srivastava, DO
Repigmentation in Vitiligo Universalis After Starting Anti-tubercular Therapy: Are They Related? - December 5, 2021 8:34 AM CTInvited Speaker #7 - Samia Esmat, MD
Vitiligo Treatment: Patient’s or Doctor's Decision ?!!
Speakers: - December 5, 2021 8:54 AM CTAbstract #15 - Rania Mogawer, MD
Efficacy of Narrow Band UVB With or Without Oral Mini-Pulse Steroids in Stabilization of Vitiligo Activity in Skin Phototypes (III -V): A Double Blind Randomized Placebo Controlled Prospective Multi-Center Study
- December 5, 2021 9:03 AM CTAbstract #16 - Marissa Ceresnie, DO
Investigating Disparities in Recording Race and Ethnicity in Vitiligo Clinical Trial Screening Assessments
- December 5, 2021 9:12 AM CTAbstract #17 - Monica Ottaviani, PhD
Vitiligo: The Skin Barrier Point of View
- December 5, 2021 9:221 AM CTAbstract # 18 - Jayvadan Vaishnav, MSc
Involvement of VTCN1 and Its Cleaving Enzyme NRD1 in Vitiligo Pathogenesis
- December 5, 2021 9:30 AM CTInvited Speaker #8 - Ahmed Mourad, MBBS, MS
Assessment of Tissue PD-1 and PD-l1 Levels in Vitiligo Patients (Case Control Study)
- December 5, 2021 9:50 AM CTPoster Q&A #4
Click here to see the virtual posters
Authors:
Sanjay Kumar, PhD
Role of Topical Methotrexate 1% Gel in Localized VitiligoParas Choudhary, MD, PhD
Microneedling With Topical 5-Fluorouracil in the Localized Stable Vitiligo – Is This the Way Out? – Our ExperienceNicoline Post, MD
Does Autoimmune Vitiligo Protect Against COVID-19 Disease?Alexandria Brown, Md, PhD
High Frequency of Photosensitizers in Products Marketed Online for Vitiligo - December 5, 2021 10:00Wrap Up and Summary of the Symposium
Join the chairs as they wrap up the day and symposium.
- December 5, 2021 10:20 AM CTVirtual Poster Session
Go online, before and after the meeting or anytime to review the submitted academic posters.
Click --> Review the iPosters from November 26, 2021 - January 31, 2022.